FDA issues warning letter to companies on dangerous, unapproved stem cell treatments - MultiBriefs Exclusive

FDA issues warning letter to companies on dangerous, unapproved stem cell treatments  MultiBriefs Exclusive

After 12 people were hospitalized for infections associated with unapproved stem cell treatments, the U.S. Food and Drug Administration (FDA) issued a warning ...